Patients are unwilling to enter clinical trialsBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6953.539b (Published 20 August 1994) Cite this as: BMJ 1994;309:539
- F Macbeth
- Christchurch Hospital, Christchurch, New Zealand.
EDITOR, - T C B Dehn is right to draw attention to the problems of obtaining informed consent from patients entering randomised trials, particularly when one option entails additional, potentially toxic treatment, such as chemotherapy.1 But Dehn's letter also illustrates the problem of avoiding bias when describing a trial: Dehn admits …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial